Listed

LifeMD, Inc.: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 15, 2019 and accepted by EDGAR at May 15, 2019, 17:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2019-01-01 to 2019-03-31$678.0kus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31$2.0mus-gaap:GrossProfit
Operating income3 months2019-01-01 to 2019-03-31−$563.4kus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$170.2kus-gaap:InterestExpense
Net income3 months2019-01-01 to 2019-03-31−$663.7kus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2019-01-01 to 2019-03-3146,806,749 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2019-01-01 to 2019-03-31$546.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-03-31$242.3kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$1.7mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$2.6mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$2.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$2.4mus-gaap:Liabilities
Shareholders' equityAt period end2019-03-31$404.6kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-19-008881. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.